Avanos Medical AVNS PM&R — Cost of goods sold

Similar metrics at other companies

ENOVPrevention & Recovery — Cost of Goods Sold

$125.76M-2.3%

TEXMP — Adjusted cost of goods sold

$318M+6.4%

BDXMedical — Cost of Products Sold as a Percent of Revenues

11.9%-0.5pp

HZOProduct Manufacturing — Cost Of Revenue

$22.42M-32.7%

THRMMedical Segments — Cost of Goods Sold

$6.1M-2.8%

MDTMedical Surgical — Cost of products sold, excluding amortization of intangible assets

$964M+10.8%

Questions, answered.

What is Avanos Medical's PM&R — cost of goods sold?

Avanos Medical (AVNS) reported PM&R — cost of goods sold of -$21.7M in Q1 2026.

How has Avanos Medical's PM&R — cost of goods sold changed year-over-year?

Avanos Medical's PM&R — cost of goods sold decreased by 4.8% year-over-year, from -$20.7M to -$21.7M.

What is the long-term trend for Avanos Medical's PM&R — cost of goods sold?

Over 2 years (2023 to 2025), Avanos Medical's PM&R — cost of goods sold has grown at a 2.2% compound annual growth rate (CAGR), from -$82M to -$85.7M.

What does PM&R — cost of goods sold mean?

Includes the direct costs attributable to the production and manufacturing of medical devices sold within the Pain Management and Recovery segment. This encompasses raw materials, direct labor, and manufacturing overheads, providing insight into the segment's production efficiency and gross margin potential.